Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Practice parameters for the management of anal fissures (revised).

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissure. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 4 p.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The levels of evidence (classes I-V) and the grades of recommendations (A-D) are defined at the end of the "Major Recommendations" field.

Treatment Recommendations

  1. Conservative therapy is safe, has few side effects, and should usually be the first step in therapy. Level of evidence: Class II; Grade of recommendation: B.
  2. Anal fissures may be appropriately treated with topical nitrates because they can relieve pain; however, nitrates are only marginally associated with a healing rate superior to placebo. Level of evidence: Class I; Grade of recommendation: A.
  3. Anal fissures may be appropriately treated with topical calcium channel blockers, which seem to have a lower incidence of adverse effects than nitrates. There is insufficient data to conclude whether they are superior to placebo in healing fissures. Level of evidence: Class I; Grade of recommendation: A.
  4. Botulinum toxin injections may be used for anal fissures that fail to respond to conservative measures and have been associated with a healing rate superior to placebo. There is inadequate consensus on dosage, precise site of administration, number of injections, or efficacy. Level of evidence: Class II; Grade of recommendation: B.
  5. Lateral internal sphincterotomy (LIS) is the surgical treatment of choice for refractory anal fissures. Level of evidence: Class I; Grade of recommendation: A.
  6. Open and closed techniques for LIS seem to yield similar results. Level of evidence: Class I; Grade of recommendation: A.
  7. Anal advancement flap is an alternative to LIS; further study is required. Level of evidence: Class II; Grade of recommendation: D.
  8. Surgery may be appropriately offered without a trial of pharmacologic treatment after failure of conservative therapy; patient should be informed about the potential complications of surgery. Level of evidence: Class I; Grade of recommendation: A.

Definitions:

Levels of Evidence (Class)

  1. Meta-analysis of multiple well-designed, controlled studies; randomized trials with low false-positive and low false-negative errors (high power)
  2. At least one well-designed experimental study; randomized trials with high false-positive or high false-negative errors or both (low power)
  3. Well-designed, quasi-experimental studies, such as nonrandomized, controlled, single-group, preoperative-postoperative comparison, cohort, time, or matched case-control series
  4. Well-designed, nonexperimental studies, such as comparative and correlational descriptive and case studies
  5. Case reports and clinical examples

Grades of Recommendations

  1. Evidence of Type I or consistent findings from multiple studies of Type II, III, or IV
  2. Evidence of Type II, III, or IV and generally consistent findings
  3. Evidence of Type II, III, or IV but inconsistent findings
  4. Little or no systematic empirical evidence

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations" field).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: Guideline was not adapted from another source.

DATE RELEASED

1992 (revised 2004 Dec)

GUIDELINE DEVELOPER(S)

American Society of Colon and Rectal Surgeons - Medical Specialty Society

SOURCE(S) OF FUNDING

Not stated

GUIDELINE COMMITTEE

Standards Task Force of the American Society of Colon and Rectal Surgeons

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Task Force Members: Charles Orsay, MD; Jan Rakinic, MD; W. Brian Perry, MD; Neil Hyman, MD; Donald Buie, MD; Peter Cataldo, MD; Graham Newstead, MD; Gary Dunn, MD; Janice Rafferty, MD; C. Neal Ellis, MD; Paul Shellito, MD; Sharon Gregorcyk, MD; Charles Ternent, MD; John Kilkenny III, MD; Joe Tjandra, MD; Clifford Ko, MD; Mark Whiteford, MD; Richard Nelson, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Society of Colon and Rectal Surgeons. Practice parameters for the management of anal fissure. Arlington Heights (IL): American Society of Colon and Rectal Surgeons; 1998-1999. 4 p.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American Society of Colon and Rectal Surgeons Web site.

Print copies: Available from the American Society of Colon and Rectal Surgeons 85 W. Algonquin Rd., Suite 550, Arlington Heights, IL 60005

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on February 15, 2000. The information was verified by the guideline developer as November 7, 2000. This NGC summary was updated by ECRI on March 3, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo